Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEOGENOMICS INC Director's Dealing 2018

Aug 3, 2018

32227_dirs_2018-08-03_54be6e3b-b859-4ffb-96b1-3f9515d26e11.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2018-08-03

Reporting Person: VAN OORT DOUGLAS M (Director, Chairman and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-08-03 Common Stock A 197042 Acquired 2030027 Direct

Footnotes

F1: This Amended Form 4 reflects the corrected presentation of a restricted stock award granted on 5/25/2017; this award was inadvertently classified in Table II and is being moved to Table I. This error also appears in the subsequent Form 4 filed on February 28, 2018.